*  Molecules | Free Full-Text | Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines
The structures of the bacterial capsular polysaccharide (CPS) antigens, extracted and purified from microbial cultures and ... While these groups are often considered important for the structural identity of the polysaccharides, they play a major role in ... has been dramatically reduced over the last 25 years through the use of glycoconjugate vaccines. ... the functional immune response to some vaccines such as meningococcal serogroup A and Salmonella typhi Vi, but do not seem to ...
  http://www.mdpi.com/1420-3049/23/6/1340
*  MRSA Infection Holistic Treatment - Ormed Medical Exchange
Bacterial Polysaccharide Vaccines Mon, 27 Mar 2017 , Vademecum Capsulated bacteria, Gram-positive or Gram-negative, cause a ... Bacterial pneumonia Last Updated on Wed, 18 Sep 2013 , Operating Room The bacteria that are most frequently found to cause ... Bacterial interactions Last Updated on Wed, 06 Apr 2016 , Cosmetic Microbiology Epithelial intestinal cells being covered with ... In vaccine studies, such viruses have been shown to retain their protective efficacy compared with their wild-type, replication ...
  https://www.ormedmedical.us/staphylococcus-aureus.html
*  Immunization of Health-Care Workers: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the...
Additional vaccines, particularly bacterial polysaccharide vaccines (i.e., Haemophilus influenzae type b {Hib} vaccine, ... after MMR vaccine, or 3 weeks after varicella vaccine. Delay administration of MMR vaccine for ,=3 months and varicella vaccine ... vaccine is used, and every 2 years if the capsular polysaccharide vaccine is used. Live-attenuated Ty21a vaccine should not be ... The safety of the vaccine in polysaccharide and by route specified HCWs in the United States. pregnant women has not vaccine ( ...
  https://www.cdc.gov/mmwr/preview/mmwrhtml/00050577.htm
*  Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons ...
... and additional vaccines, particularly bacterial polysaccharide vaccines {Haemophilus influenzae type b (Hib), pneumococcal and ... Some antigens, particularly bacterial polysaccharide vaccines, are recommended for such patients. Frequently, the immune ... see discussion under Pneumococcal vaccine). Quadrivalent meningococcal polysaccharide vaccine also should be administered to ... vaccines or higher doses of vaccines but that do not contraindicate use of any particular vaccine. ...
  https://www.cdc.gov/mmwr/preview/mmwrhtml/00023141.htm
*  Selective Antibody Deficiency - The Clinical Advisor
"Evaluating children with respiratory tract infections: the role of immunization with bacterial polysaccharide vaccine". Pediatr ... Because the B cell defect is limited to polysaccharide antigens, immunization with conjugated vaccines such as H flu vaccine ... By conjugating polysaccharide antigens with proteins, as in the heptavalent and 13-valent pneumococcal polysaccharide vaccines ... Bacterial cell wall polysaccharides are classified as T independent antigens, meaning they can stimulate B cells directly and ...
  http://www.clinicaladvisor.com/pediatrics/selective-antibody-deficiency/article/623992/
*  What Is and What Should Always Have Been: Long-Lived Plasma Cells Induced by T Cell-Independent Antigens | The Journal of...
1A). As a consequence, few polysaccharide vaccines consisting of bacterial capsule Ags are currently available. One noteworthy ... Indeed, whereas vaccines to T cell-dependent Ags are more likely to be long-lasting, those against certain T cell-independent ... For responses to polysaccharides, classically referred to as type 2 T cell-independent Ags, Taillardet et al. (38) demonstrated ... Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357: 1903-1915. ...
  http://www.jimmunol.org/content/190/12/5913
*  Meet Our Authors - February Special Dendrimer Issue 2012 - NJC Blog
René and his collaborators have contributed to the commercialization of two bacterial polysaccharide-based vaccines against ... Glycodendrimers as functional antigens and antitumor vaccines by Tze Chieh Shiao and René Roy; New J. Chem., 2012, 36, 324-339 ... he highlights recent developments in the chemical synthesis of carbohydrate-associated cancer vaccines that include the use of ...
  http://blogs.rsc.org/nj/2012/02/14/meet-our-authors-%E2%80%93-february-special-dendrimer-issue-2012/?doing_wp_cron=1516269519.7133929729461669921875
*  Hib vaccine - Wikipedia
Finn, Adam (2004-01-01). "Bacterial polysaccharide-protein conjugate vaccines". British Medical Bulletin. 70 (1): 1-14. doi: ... The shortcomings of the polysaccharide vaccine led to the production of the Hib polysaccharide-protein conjugate vaccine. ... The first Hib vaccine licensed was a pure polysaccharide vaccine, first marketed in the US in 1985. Similar to other ... All Hib vaccines that are currently used are conjugate vaccine. An initial Hib vaccine was developed in 1977 which was replaced ...
  https://en.wikipedia.org/wiki/Hib_vaccine
*  George Siber bibliography - Wikipedia
... diphtheria toxoid conjugate vaccine given with or without bacterial polysaccharide immune globulin (BPIG) in Navajo infants. ... "Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine ... diphtheria toxoid conjugate vaccine given with or without Bacterial Polysaccharide Immune Globulin (BPIG). Interscience ... "Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients ...
  https://en.wikipedia.org/wiki/George_Siber_bibliography
*  Pneumococcal Polysaccharide Vaccine (23-Valent) (Professional Patient Advice) - Drugs.com
Professional guide for Pneumococcal Polysaccharide Vaccine (23-Valent). Includes: pharmacology, pharmacokinetics, ... Vaccine, Inactivated (Bacterial). Pharmacology. Pneumococcal polysaccharide polyvalent is an inactive bacterial vaccine that ... Pneumococcal vaccine-naive or vaccination status unknown: Administer PCV13 followed by pneumococcal polysaccharide vaccine ( ... Zoster Vaccine (Live/Attenuated): Pneumococcal Polysaccharide Vaccine (23-Valent) may diminish the therapeutic effect of Zoster ...
  https://www.drugs.com/ppa/pneumococcal-polysaccharide-vaccine-23-valent.html
*  Pathogenic Bacterial Sensors Based on Carbohydrates as Sensing Elements | Springer for Research & Development
Lee CJ (1987) Bacterial Capsular Polysaccharides - Biochemistry, Immunity and Vaccine. Mol Immunol 24:1005-1019Google Scholar ... Sood RK, Fattom A, Pavliak V and Naso RB (1996) Capsular polysaccharide-protein conjugate vaccines. Drug Discov Today 1:381-387 ... Moxon ER and Kroll JS (1990) The Role of Bacterial Polysaccharide Capsules as Virulence Factors. Curr Top Microbiol Immunol 150 ... Weintraub A (2003) Immunology of bacterial polysaccharide antigens. Carbohydr Res 338:2539-2547Google Scholar ...
  https://rd.springer.com/chapter/10.1007/978-0-387-75113-9_24
*  Practical Fragments: May 2015
For Streptococcus pneumoniae, there are a numbers of vaccines on the market. These vaccines are bacterial polysaccharides ... transport across the bacterial cell membrane. (See there's always a metal involved in cool biology.) This makes PsaA a good ...
  http://practicalfragments.blogspot.co.uk/2015/05/
*  Preventing Pneumococcal Disease Among Infants and Young Children
PNEUMOCOCCAL CONJUGATE VACCINE Advantages of Pneumococcal Conjugate Vaccine: Immunologic Theory Bacterial polysaccharides, ... conjugate vaccine followed, ,2 months later, by 23-valent polysaccharide vaccine. Conjugate vaccine has not been studied ... In February 2000, a 7-valent pneumococcal polysaccharide-protein conjugate vaccine (Prevnar, marketed by Wyeth Lederle Vaccines ... Vaccine Composition The 7-valent pneumococcal conjugate vaccine (Prevnar) includes seven purified capsular polysaccharides of S ...
  https://www.cdc.gov/MMWR/preview/MMWRhtml/rr4909a1.htm
*  Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials | Nutrition & Metabolism | Full...
... as the vaccine is made of bacterial sugars from 23 pneumococcal types. Vaccines produced from bacterial polysaccharides are ... Larch arabinogalactanCommon cold infectionsImmune systemVaccineSCFAPolysaccharidesDietary fibersResistAid® Larix ... Polysaccharides from Larch Biomass. In: Karunaratne DDN, editor. The Complex World of Polysaccharides. InTech; 2012.Google ... Section1: General aspects of vaccination - Chapter 2: Vaccine immunology. In: al Se, editor. Vaccines. 5th ed. Amsterdam: W.B. ...
  https://nutritionandmetabolism.biomedcentral.com/articles/10.1186/s12986-016-0086-x
*  2005, November - Journal of Young Investigators
To overcome these inherent limitations of polysaccharide antigens, new vaccine formulations have coupled bacterial ... The vaccines which we are going to consider here are non-genetic vaccines, or in simple terms, the components of these vaccines ... whereby a bacterial surface molecule binds tightly to a receptor. The bacterial molecule is expressed over the entire bacterial ... REVIEW: Mechanisms of Bacterial Pathogenesis and Targets for Vaccine Design Chief Technology Officer ...
  https://www.jyi.org/2005-november
*  Host Defenses to Intracellular Pathogens | SpringerLink
... and the importance of cross-reacting bacterial polysaccharide antigens in vaccine development. A major portion of the course ... BCG Cell Mediated Lysis Cellular Processing Interferon Lymphocytes Expressing Bacterial Antigens Mechanisms Distinct Salmonella ... encompassing topics as diverse as the mechanisms of action of bacterial toxins, the role of complement and antibody in ...
  https://link.springer.com/book/10.1007%2F978-1-4684-4481-0
*  Aalysis of immune receptor diversity and oligoclonality in responses to vaccinati - Andrew Fire
... immune receptor populations in adults before and following immunization with a conjugated bacterial polysaccharide vaccine ( ... and bacterial (meningococcal) vaccines, as well as natural infections with HI N1 influenza and varicella zoster. Our initial ... Characterize immune receptor populations in adults before and following immunization with influenza H1N1 vaccine and following ... will aid the design and testing of new vaccines. ... following protective vaccination against viral and bacterial ...
  http://grantome.com/grant/NIH/U19-AI090019-05-7081
*  Liquidia Technologies Highlights Its Transformative Print® Technology at the 12th International Nanomedicine and Drug Delivery...
Nanoparticle Vaccine Carrying Bacterial Polysaccharide and Protein Antigens Induces Enhanced B- and T-Cell (IL-17) Immunity. ... and composition of vaccines with the goal of optimizing a vaccine's ability to elicit the desired immune response. By using a ... of the challenges often encountered in vaccine development with the ultimate goal of creating safe and efficacious vaccines ... and vaccines. In addition to the development of its own products, Liquidia licenses the PRINT particle technology and its cGMP ...
  http://liquidia.com/liquidia-technologies-highlights-transformative-print-technology-12th-international-nanomedicine-drug-delivery-symposium/
*  Addressing Parents' Concerns: Do Vaccines Contain Harmful Preservatives, Adjuvants, Additives, or Residuals? | Special Articles...
... or bacterial polysaccharides. In addition to these immunogens, vaccines often contain other substances. For example, vaccines ... mumps vaccine (Mumpsvax; Merck and Co); rubella vaccine (Meruvax; Merck and Co); and measles, mumps, and rubella vaccine (MMRII ... First, DTaP vaccines made in Japan contained gelatin, whereas DTaP vaccines made in the United States did not.48 Second, the ... Vaccines contain live viruses, killed viruses, purified viral proteins, inactivated bacterial toxins, ...
  http://pediatrics.aappublications.org/content/112/6/1394
*  Meningococcal polysaccharide vaccine Uses, Side Effects & Warnings - Drugs.com
... includes meningococcal polysaccharide vaccine description, dosage and directions. ... Drug class: bacterial vaccines. Consumer resources. *Meningococcal Polysaccharide Vaccine (Groups A / C / Y and W-135) ... meningococcal polysaccharide vaccine. Generic Name: meningococcal polysaccharide vaccine (me NIN je KOK al POL ee SAK a ride ... How is this vaccine given?. Meningococcal polysaccharide vaccine is recommended if:. * you are older than 55 years and you live ...
  https://www.drugs.com/mtm/meningococcal-polysaccharide-vaccine.html
*  Production of glycoprotein vaccines in Escherichia coli | Microbial Cell Factories | Full Text
Robbins JB, Schneerson R, Szu SC, Pozsgay V: Bacterial polysaccharide-protein conjugate vaccines. Pure Appl Chem. 1999, 71 (5 ... In contrast to isolated bacterial polysaccharides, conjugate vaccines induce a long-lasting T-lymphocyte dependent ... Conjugate vaccines in which polysaccharide antigens are covalently linked to carrier proteins belong to the most effective and ... Lockhart S: Conjugate vaccines. Expert Rev Vaccines. 2003, 2 (5): 633-648. 10.1586/14760584.2.5.633.View ArticleGoogle Scholar ...
  https://microbialcellfactories.biomedcentral.com/articles/10.1186/1475-2859-9-61
*  Microparticles with adsorbed polypeptide-containing molecules - Patent # 7501134 - PatentGenius
Preferred polypeptide containing molecules are bacterial and viral antigens (including HIV antigens, meningitis B antigens, ... Constantino et al., "Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines," Vaccine, ... 1992) Vaccine 10:691-698 (Ref. 12); Costantino et al. (1999) Vaccine 17:1251-1263 (Ref. 13); Watson (2000)Padiatr Infect Dis J ... See, e.g., "HBV Vaccines--from the laboratory to license: a case study" in Mackett, M. and Williamson, J. D., Human Vaccines ...
  http://www.patentgenius.com/patent/7501134.html
*  Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines - Full Text View - ClinicalTrials.gov
... a vaccine that treats a common bacterial infection) in healthy non-pregnant women. ... Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines. The safety and scientific validity of this ... Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines. Estimated Study Completion Date :. November ... Bacterial Infections Group B Streptococcus Biological: GBS III-TT-SSI Biological: GBS III-TT-MPHL Phase 1 ...
  https://clinicaltrials.gov/ct2/show/NCT00008853